Back

T cells are necessary for development of PCOS reproductive symptoms in a letrozole-induced mouse model of PCOS

Ujagar, N.; Velez, L.; De Robles, G.; Nguyen, C.; Wiggins, K.; Kim, J.; Naidu, N.; Angulo, J. A.; Kaufmann, A. S.; Thackray, V. G.; Banaszewska, B.; Wysocka, E.; Duleba, A.; Seldin, M. M.; Nicholas, D. A.

2025-01-13 immunology
10.1101/2025.01.08.631835 bioRxiv
Show abstract

Polycystic ovary syndrome (PCOS) is a complex condition with clear genetic susceptibilities that impact the heterogeneous clinical presentation of symptoms and severity through unknown mechanisms. Chronic inflammation is linked to PCOS, but a clear cause-and-effect relationship has yet to be established. This study used an in depth systems immunology approach and a letrozole-induced PCOS mouse model to identify changes in inflammatory factors associated with PCOS symptoms. By analyzing immune cells and secreted cytokines from 22 different mouse strains, we identified TNF-{beta} as a key T cell-derived cytokine associated with PCOS, regardless of genetic background. We confirmed elevated TNF-{beta} transcripts in immune cells from women with PCOS. Importantly, we used a knockout of TCR to show that functional T cells are a necessary component of driving PCOS features in letrozole-treated female mice. These findings implicate T cells and specifically TNF-{beta} production in the development of PCOS impairments. T cells are therefore an attractive target for the future development of anti-inflammatory therapeutics to improve PCOS symptoms. TeaserTNF-{beta} links T cell inflammation to reproductive dysfunction in PCOS, highlighting new therapeutic targets for this disorder.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.